IL-7 in the cell-mediated immune response to a human pathogen - PubMed (original) (raw)
. 1995 Mar 15;154(6):2775-83.
Affiliations
- PMID: 7876548
IL-7 in the cell-mediated immune response to a human pathogen
P A Sieling et al. J Immunol. 1995.
Abstract
The goal of the present study was to investigate the role of IL-7 in regulating immune responses to infection. Leprosy provides a model for understanding human immune responses to infection; the disease presents as a spectrum in which the clinical manifestations correlate with the levels of cell-mediated immunity to the pathogen, Mycobacterium leprae. To determine whether IL-7 is produced at the site of infection in leprosy, we used the PCR to measure IL-7 and IL-7R mRNA in skin lesions. IL-7 mRNA was more strongly expressed in the tuberculoid form of the disease, in which the infection is limited (mean cpm = 48 +/- 8; n = 11), as compared with the progressive lepromatous form (17 +/- 2; n = 11). IL-7R mRNA, both membrane-bound and soluble forms, were also more strongly expressed in tuberculoid lesions, although these differences were not as striking as those for IL-7. The cellular source of IL-7 included Ag-stimulated monocytes and IFN-gamma-induced keratinocytes. M. leprae-induced PBMC responses in tuberculoid patients involved up-regulation of IL-7 and IL-7R mRNA and was IL-7 dependent. In contrast, M. leprae did not induce IL-7 mRNA in lepromatous patients, and their T cell responses were weakly augmented by rIL-7. These data suggest that IL-7, produced at the site of disease, contributes to the cell-mediated immune response to human pathogens.
Similar articles
- IL-15, an immunomodulator of T cell responses in intracellular infection.
Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL. Jullien D, et al. J Immunol. 1997 Jan 15;158(2):800-6. J Immunol. 1997. PMID: 8992997 - Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL. Sieling PA, et al. J Immunol. 1993 Jun 15;150(12):5501-10. J Immunol. 1993. PMID: 8515073 - HLA and leprosy in the pre and postgenomic eras.
Geluk A, Ottenhoff TH. Geluk A, et al. Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review. - The immunobiology of leprosy.
Kaplan G, Cohn ZA. Kaplan G, et al. Int Rev Exp Pathol. 1986;28:45-78. Int Rev Exp Pathol. 1986. PMID: 3516911 Review.
Cited by
- Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes.
Pandit H, Valentin A, Angel M, Deleage C, Bergamaschi C, Bear J, Sowder R, Felber BK, Pavlakis GN. Pandit H, et al. iScience. 2023 Jan 5;26(2):105929. doi: 10.1016/j.isci.2023.105929. eCollection 2023 Feb 17. iScience. 2023. PMID: 36685042 Free PMC article. - IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.
Logerot S, Figueiredo-Morgado S, Charmeteau-de-Muylder B, Sandouk A, Drillet-Dangeard AS, Bomsel M, Bourgault-Villada I, Couëdel-Courteille A, Cheynier R, Rancez M. Logerot S, et al. Front Immunol. 2021 Feb 25;12:614115. doi: 10.3389/fimmu.2021.614115. eCollection 2021. Front Immunol. 2021. PMID: 33717097 Free PMC article. - In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae.
van Hooij A, Geluk A. van Hooij A, et al. Immunol Rev. 2021 May;301(1):175-192. doi: 10.1111/imr.12966. Epub 2021 Mar 11. Immunol Rev. 2021. PMID: 33709405 Free PMC article. Review. - Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.
Kisia LE, Kempaiah P, Anyona SB, Munde EO, Achieng AO, Ong'echa JM, Lambert CG, Chelimo K, Ouma C, Perkins DJ, Raballah E. Kisia LE, et al. BMC Med Genet. 2019 Aug 16;20(1):140. doi: 10.1186/s12881-019-0866-z. BMC Med Genet. 2019. PMID: 31420016 Free PMC article. - Low Interleukin-7 Receptor Messenger RNA Expression Is Independently Associated With Day 28 Mortality in Septic Shock Patients.
Delwarde B, Peronnet E, Venet F, Cerrato E, Meunier B, Mouillaux J, Lepape A, Pachot A, Rimmelé T, Monneret G, Textoris J; Marqueurs Immunitaires Pronostiques en Réanimation (MIP Réa) Study Group. Delwarde B, et al. Crit Care Med. 2018 Nov;46(11):1739-1746. doi: 10.1097/CCM.0000000000003281. Crit Care Med. 2018. PMID: 29985808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical